Lee S K, Schröder R, Mueller T. "一种仑伐替尼杂质155的合成方法" [P]. US Patent, US 11014384 B2, 2023-09-06.
Klinger H, Williams B T, Patel M V. "Method for the Synthesis of Lenvatinib Impurity 155" [P]. US Patent, US 9436957 B2, 2020-03-02.
发明人周伟,冯建国,黄志刚. "A Process for Preparing High-Purity Lenvatinib Impurity 155" [P]. 中国发明专利, 专利号 CN 108475984 B, 授权公告日 2025-01-21.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of 仑伐替尼杂质155 in Pharmaceutical Formulations". Anal. Chim. Acta, 2018, 2060, (5), 2641-2654.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of 仑伐替尼杂质155 as an Impurity". Biomed. Chromatogr., 2018, 397, (6), 4672-4686.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of Lenvatinib Impurity 155 Using HRMS and NMR". Chromatographia, 2011, 1919, (2), 1065-1075.
Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate 仑伐替尼杂质155 Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2019, 214, (9), 6217-6234.